Phosphorus

Identification

Summary

Phosphorus is a medication indicated in the treatment of hypophosphatemia.

Generic Name

Phosphorus

DrugBank Accession Number

DB14151

Background

Not Available

Type

Small Molecule

Groups

Approved, Experimental

Structure

Download

MOLSDFPDBSMILESInChI

Similar Structures

Structure for Phosphorus (DB14151)

×

Close

Weight

Average: 30.9738
Monoisotopic: 30.973761512

Chemical Formula

P

Synonyms

• Phosphorous
• Phosphorus, elemental

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates

Build, train, & validate machine-learning models
with evidence-based and structured datasets.

See how

Build, train, & validate predictive machine-learning models with structured datasets.

See how

Associated Conditions

Indication Type	Indication	Combined Product Details	Approval Level	Age Group	Patient Characteristics	Dose Form
Used in combination to prevent	Bone loss	Combination Product in combination with: Cholecalciferol (DB00169), Calcium (DB01373)	••• •••			•••••••

Create Account

Associated Therapies

• Nutritional supplementation

Contraindications & Blackbox Warnings

Prevent Adverse Drug Events Today

Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.

Learn more

Avoid life-threatening adverse drug events with our Clinical API

Learn more

Pharmacodynamics

Not Available

Mechanism of action

Not Available

Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Not Available

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects

Improve decision support & research outcomes

With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!

See the data

Improve decision support & research outcomes with our structured adverse effects data.

See a data sample

Toxicity

Not Available

Pathways

Not Available

Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">

Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.

Not Available

Food Interactions

No interactions found.

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End	Region	Image
Advanced B & T Formula	Phosphorus (100 mg) + Ascorbic acid (33.3 mg) + Calcium (200 mg) + Chromium (33.33 mcg) + Copper (0.5 mg) + Cyanocobalamin (6.67 mcg) + Folic acid (0.133 mg) + Iron (1.67 mg) + Magnesium (83.3 mg) + Manganese (3.33 mg) + Nicotinamide (6.67 mg) + Calcium pantothenate (5 mg) + Potassium (16.67 mg) + Pyridoxine hydrochloride (6.67 mg) + Riboflavin (2.67 mg) + Selenium (33.33 mcg) + Silicon (0.333 mg) + Sodium molybdate (16.67 mcg) + Thiamine (2.67 mg) + Vanadium (8.33 mg) + Vitamin D (66.67 unit) + Zinc (5 mg)	Capsule	Oral	Nutraceutical Corporation	Not applicable	Not applicable
Anaplex Tab	Phosphorus (75.33 mg / tab) + Ascorbic acid (40 mg / tab) + Calcium (160 mg / tab) + Iodine (.05 mg / tab) + Magnesium oxide (50 mg / tab) + Nicotinamide (30 mg / tab) + Calcium pantothenate (15 mg / tab) + Potassium chloride (20 mg / tab) + Pyridoxine hydrochloride (40 mg / tab) + Vitamin A palmitate (2000 unit / tab) + Vitamin D (133.33 unit / tab)	Tablet	Oral	Anabolic Laboratories Inc.	1975-12-31	1996-10-02
Calci A and D Tab	Phosphorus (70 mg) + Calcium (165 mg) + Vitamin A (1000 unit) + Vitamin D (100 unit)	Tablet	Oral	Pharmetics (2011) Inc.	1981-12-31	2006-07-27
Calcium Phosphorus & Vitamin D	Phosphorus (97 mg / tab) + Calcium (215 mg / tab) + Vitamin D (100 unit / tab)	Tablet	Oral	Avacare, Division Of Jeunique International Inc.	1985-12-31	1996-09-09
Chelamins Plus Tab	Phosphorus (75 mg) + Calcium (350 mg) + Chromium (50 mcg) + Copper (1.5 mg) + Iodine (.15 mg) + Iron (15 mg) + Magnesium (175 mg) + Manganese (5 mg) + Potassium (47.5 mg) + Selenium (25 mcg) + Vitamin D (200 unit) + Zinc (11.25 mg)	Tablet	Oral	Nu Life Nutrition Ltd.	1988-12-31	2000-03-03

Categories

Drug Categories

• Elements

Classification

Not classified

Affected organisms

Not Available

Chemical Identifiers

UNII

27YLU75U4W

CAS number

7723-14-0

InChI Key

OAICVXFJPJFONN-UHFFFAOYSA-N

InChI

InChI=1S/P

IUPAC Name

phosphorus

SMILES

[P]

References

General References

1. TITCK: Megadyn Pronatal (Multivitamin) Oral Tablet [Link]

External Links

Human Metabolome Database

HMDB0001315

ChemSpider

4575369

RxNav

8263

ChEBI

30207

Wikipedia

Phosphorus

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">

Phase	Status	Purpose	Conditions	Count
4	Recruiting	Treatment	X-Linked Hypophosphatemia	1
3	Unknown Status	Treatment	Chronic Kidney Disease (CKD)	1
2, 3	Completed	Treatment	Overweight / Pregnancy / Psychiatric Disorder NOS	1
1, 2	Completed	Treatment	Dent's Disease	1
Not Available	Completed	Not Available	Chronic Kidney Disease (CKD)	1

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Tablet, film coated	Oral
Tablet
Capsule
Tablet	Oral
Liquid	Oral
Capsule	Oral
Capsule, gelatin coated	Oral
Powder	Oral

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
logP	0.3	Chemaxon
Physiological Charge	0	Chemaxon
Hydrogen Acceptor Count	0	Chemaxon
Hydrogen Donor Count	0	Chemaxon
Polar Surface Area	0 Å2	Chemaxon
Rotatable Bond Count	0	Chemaxon
Refractivity	5.2 m3·mol-1	Chemaxon
Polarizability	1.78 Å3	Chemaxon
Number of Rings	0	Chemaxon
Bioavailability	1	Chemaxon
Rule of Five	Yes	Chemaxon
Ghose Filter	No	Chemaxon
Veber's Rule	Yes	Chemaxon
MDDR-like Rule	No	Chemaxon

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Spectrum	Spectrum Type	Splash Key
Predicted GC-MS Spectrum - GC-MS	Predicted GC-MS	splash10-001i-9000000000-88317f9b56fea79262a0
Predicted MS/MS Spectrum - 10V, Positive (Annotated)	Predicted LC-MS/MS	splash10-001i-9000000000-b25ebf44fa1deb41a771
Predicted MS/MS Spectrum - 20V, Positive (Annotated)	Predicted LC-MS/MS	splash10-001i-9000000000-b25ebf44fa1deb41a771
Predicted MS/MS Spectrum - 40V, Positive (Annotated)	Predicted LC-MS/MS	splash10-001i-9000000000-b25ebf44fa1deb41a771

Chromatographic Properties

Collision Cross Sections (CCS)

Adduct	CCS Value (Å2)	Source type	Source
[M-H]-	108.291565	predicted	DeepCCS 1.0 (2019)
[M+H]+	110.04523	predicted	DeepCCS 1.0 (2019)
[M+Na]+	116.777725	predicted	DeepCCS 1.0 (2019)

×

Identify potential medication risks

Easily compare up to 40 drugs with our drug interaction checker.

Get severity rating, description, and management advice.

Learn more

Drug created at June 28, 2018 19:42 / Updated at May 14, 2021 01:06